PubMed Health⌕ Search

PubMed · 12197423

Prescribing patterns analysis in Bulgaria.

Abstract

This study was developed to assess the prescribing patterns in the reimbursable and non-reimbursable prescriptions during 1996-2000 and their relevance to morbidity patterns in Bulgaria. It was manually collected 2266 reimbursable and 2330 non-reimbursable prescriptions with 4132 and 4291 prescribed drugs, respectively. The results shows that the leading causes for morbidity during 1995-99 were respiratory tract diseases with 40% relative share, followed by nervous system diseases with 12% share, cardiovascular diseases 10% share, digestive tract diseases, genito-urinary, skin and subcutaneous tissue diseases. All mentioned groups of diseases together with injuries and poisoning perform 70% of the total morbidity of the population. The prevailing causes for the mortality of the population were found to be cardiovascular, respiratory tract diseases, injuries and poisoning. The analysis of the collected prescriptions evaluated as mot often prescribed cardiovascular drugs (35%), drugs acting on digestive system (18%), nervous system (12%), respiratory system (11%) and anti-infective drugs (10%). In spite of the relevance among the prescribing and morbidity a lot of other factors are considered to be important as reimbursement system, pricing, and legislation.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Guenka I Petrova. Prescribing patterns analysis in Bulgaria.. https://pubmed.ncbi.nlm.nih.gov/12197423/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

IGF1, growth pathway polymorphisms and schizophrenia: a pooling study.

It has been hypothesized that insulin-like growth factors (IGFs) and components of the growth-hormone (GH)-IGF axis may underlie reported associations of poor fetal and childhood growth with schizophrenia. We have investigated the association of schizophrenia with 16 SNPs spanning the IGF1 gene with an inter-marker distance of approximately 2-3 kb. We also examined associations with four common functional polymorphisms of genes involved in aspects of the GH-IGF system--the IGF1 receptor (IGF1R), insulin receptor substrate (IRS1), growth hormone (GH1), and IGF binding protein-3 (IGFBP3). The study was based on an analysis of pooled DNA samples from 648 UK and Irish cases of schizophrenia and 712 blood donor controls and of 297 Bulgarian parent offspring trios. In replicated pool analyses, none of the 16 SNPs in IGF1 nor the 4 key SNPs in the other growth pathway genes were associated with schizophrenia. SNP coverage of IGF1 was extensive, so our findings do not support a major role for IGF-I in the aetiology of schizophrenia.

Bulgaria↗